Key Predictors of Rheumatoid Arthritis Flares Identified
Baseline methotrexate use has been found to be able to predict remission flare ups in patients with rheumatoid arthritis.
Read More
Author: Teresa Sellinger
Anti-Ro/SSA Antibodies in Systemic Sclerosis: a Novel Predictor of Severe Lung Involvement
Research suggests including anti-SSA antibodies in routine clinical practice could notably improve the risk stratification of patients with SSc
Read More
Dual IL-17 Blocker Significantly Reduces Spinal Radiographic Progression in R-axSpA
Bimekizumab has been found to minimize spinal radiographic progression in patients with radiographic axial spondyloarthritis.
Read More
Molecular Testing Appears To Be Increasing in eNSCLC
An increasing number of patients with eNSCLC currently have access to biomarker testing and targeted therapies, according to the MYLUNG consortium.
Read More
Spotlight On the 42nd ASRS Annual Scientific Meeting July 17-20
Immerse yourself in retinal science advancements, therapeutics, innovation and fellowship at the 42nd ASRS Annual Scientific Meeting July 17-20, 2024.
Read More
Achilles Tendon Involvement in PsA Linked to Persistent Pain and Severe Functional Impairment
Structural and functional differences in the Achilles tendon could be clinically relevant when managing pain in patients with psoriatic arthritis.
Read More
Zanubrutinib Plus Venetoclax Shows Promise in Del(17p)/TP53-Mutated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Zanubrutinib plus venetoclax delivered promising preliminary efficacy results in newly diagnosed CLL/SLL in participants with del(17p) and/or TP53 mutations.
Read More
Mosunetuzumab Benefits Outcomes Across Follicular Lymphoma Subgroups
Patients with pre-treated relapsed or refractory follicular lymphoma have shown benefits with mosunetuzumab.
Read More
Promising Results for Anitocabtagene Autoleucel Therapy in Multiple Myeloma
Anitocabtagene autoleucel therapy showed promising results in patients with relapsed or refractory multiple myeloma.
Read More
Revumenib Displays Encouraging Anti-Tumor Activity in KMT2Ar Acute Leukemia, AUGMENT-101 Trial Stopped Early
The AUGMENT-101 trial in patients with in KMT2Ar leukemia has been stopped early because of revumenib encouraging anti-tumor activity.
Read More
Is Pelabresib + Ruxolitinib the Paradigm-Shifting Combo Therapy for Myelofibrosis?
Pelabresib plus ruxolitinib has shown efficacy in the treatment responses of patients with myelofibrosis.
Read More
Sovleplenib Delivers Durable Responses and QOL Improvements in Primary Immune Thrombocytopenia
Sovleplenib may offer QOL improvements for patients with primary immune thrombocytopenia.
Read More
Multiple Novel Oral Agents Show Promise in Psoriasis
Oral agents have show good efficacy results in patients with psoriasis. An oral agent is also easier for patients to intake then other forms of medication.
Read More
The Unfavorable Role of Obesity in Psoriatic Disease
The association between obesity and psoriatic disease. Smoking, genetics, as well as obesity, all potentially contribute to the development of psoriasis in all age groups.
Read More
Depression Complicates Management of Psoriatic Disease
In a new study, researchers explore the relationship between psoriasis and depression, and how depression can be addressed with different forms of therapy.
Read More
How Close Are We to Personalized Medicine in Psoriatic Arthritis?
With new research, medical professionals are even closer to implementing personalized medicine in care for patients with psoriatic arthritis.
Read More
Genetic and Immunological Advances in Risk Assessment and Treatment of Psoriatic Diseases
Immunological and genetic studies are changing the way medical professionals understand psoriatic disease, the risks, and how patients could respond to treatment.
Read More
Analysis of Synovial Tissue Macrophages: A Way to Predict RA Treatment Response?
Multimodal analysis of synovial tissue may identify patients with rheumatoid arthritis who subsequently respond to treatment with DMARDs.
Read More
Safety and Efficacy of Interatrial Shunts for HFrEF Treatment
Interatrial shunts have a future in patients with HFrEF. However, if used at all, this shunt would have to be carefully considered in patients with HFpEF.
Read More
Adding Albumin to VACS 2.0 Improves Correlations in Patients With HIV
Adding albumin to the Veterans Aging Cohort Study Index 2.0 improved correlations with neuropsychological performance and frailty among patients with HIV.
Read More